Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 179, doi. 10.1177/1740774515569612
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2015 AND VI 12 AND IP 2
Results: 21
1
2
Marvin Zelen, 1927–2014.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
3
A note on masking in the SOX trial.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 177, doi. 10.1177/1740774515569854
- By:
- Publication type:
- Article
4
Ethical concerns about adaptive randomization.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 101, doi. 10.1177/1740774515569613
- By:
- Publication type:
- Article
5
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 122, doi. 10.1177/1740774515569611
- By:
- Publication type:
- Article
6
Rejoinder.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 125, doi. 10.1177/1740774515569014
- By:
- Publication type:
- Article
7
Marvin Zelen, 1927–2014.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 183, doi. 10.1177/1740774515569013
- By:
- Publication type:
- Article
8
Response.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 178, doi. 10.1177/1740774515569012
- By:
- Publication type:
- Article
9
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 107, doi. 10.1177/1740774515569011
- By:
- Publication type:
- Article
10
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 116, doi. 10.1177/1740774515568917
- By:
- Publication type:
- Article
11
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 119, doi. 10.1177/1740774515568916
- By:
- Publication type:
- Article
12
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 110, doi. 10.1177/1740774514568875
- By:
- Publication type:
- Article
13
Commentary on Hey and Kimmelman.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 113, doi. 10.1177/1740774514568874
- By:
- Publication type:
- Article
14
Missing not at random models for masked clinical trials with dropouts.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 139, doi. 10.1177/1740774514566662
- By:
- Publication type:
- Article
15
Suspension of accrual in phase II cancer clinical trials.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 128, doi. 10.1177/1740774514562029
- By:
- Publication type:
- Article
16
Are outcome-adaptive allocation trials ethical?
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 102, doi. 10.1177/1740774514563583
- By:
- Publication type:
- Article
17
Clinician-trialist rounds: 26. Sabbaticals. Part 1: Should I take a sabbatical?
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 174, doi. 10.1177/1740774514562917
- By:
- Publication type:
- Article
18
Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: The Breastfeeding, Antiretrovirals and Nutrition study experience.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 156, doi. 10.1177/1740774514562031
- By:
- Publication type:
- Article
19
E-health data to support and enhance randomised controlled trials in the United Kingdom.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 180, doi. 10.1177/1740774514562030
- By:
- Publication type:
- Article
20
Automated measurements for individualized heart rate correction of the QT interval.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 149, doi. 10.1177/1740774514566332
- By:
- Publication type:
- Article
21
The impact of registration of clinical trials units: The UK experience.
- Published in:
- Clinical Trials, 2015, v. 12, n. 2, p. 166, doi. 10.1177/1740774514561242
- By:
- Publication type:
- Article